世界の臨床栄養市場2020-2024

【英語タイトル】Global Clinical Nutrition Market 2020-2024

Technavioが出版した調査資料(IRTNTR43306)・商品コード:IRTNTR43306
・発行会社(調査会社):Technavio
・発行日:2020年5月4日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、アジア太平洋、ヨーロッパ、その他
・産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは臨床栄養の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、投与経路別(経管栄養、非経口栄養)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・臨床栄養設備の世界市場:投与経路別(経管栄養、非経口栄養)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Clinical Nutrition Market 2020-2024

Technavio has been monitoring the clinical nutrition market and it is poised to grow by $ 21.47 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on clinical nutrition market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising geriatric population and increasing number of premature births in developing countries. In addition, rising geriatric population is anticipated to boost the growth of the market as well.

The clinical nutrition market analysis includes route of administration segment and geographic landscapes
Technavio’s clinical nutrition market is segmented as below:
By Route Of Administration
• Enteral nutrition
• Parenteral nutrition

By Geographic Landscapes
• North America
• APAC
• Europe
• ROW

This study identifies the increased number of medical emergencies and hospital admissions as one of the prime reasons driving the clinical nutrition market growth during the next few years.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our clinical nutrition market covers the following areas:
• Clinical nutrition market sizing
• Clinical nutrition market forecast
• Clinical nutrition market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical nutrition market vendors that include Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Lonza Group Ltd., Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, and Sanofi. Also, the clinical nutrition market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-clinical-nutrition-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Route of Administration
o Market segments
o Comparison by Route of Administration
o Enteral nutrition – Market size and forecast 2019-2024
o Parenteral nutrition – Market size and forecast 2019-2024
o Market opportunity by Route of Administration
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o 8.1 Volume driver – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o B. Braun Melsungen AG
o Baxter International Inc.
o Fresenius SE & Co. KGaA
o GlaxoSmithKline Plc
o Lonza Group Ltd.
o Nestle SA
o Pfizer Inc.
o Reckitt Benckiser Group Plc
o Sanofi
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Other1 – Market share 2019-2024 (%)
• 22: Comparison by Other1
• 23: Enteral nutrition – Market size and forecast 2019-2024 ($ million)
• 24: Enteral nutrition – Year-over-year growth 2019-2024 (%)
• 25: Parenteral nutrition – Market size and forecast 2019-2024 ($ million)
• 26: Parenteral nutrition – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Other1
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: APAC – Market size and forecast 2019-2024 ($ million)
• 34: APAC – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories – Overview
• 48: Abbott Laboratories – Business segments
• 49: Abbott Laboratories – Key offerings
• 50: Abbott Laboratories – Key customers
• 51: Abbott Laboratories – Segment focus
• 52: B. Braun Melsungen AG – Overview
• 53: B. Braun Melsungen AG – Business segments
• 54: B. Braun Melsungen AG – Key offerings
• 55: B. Braun Melsungen AG – Key customers
• 56: B. Braun Melsungen AG – Segment focus
• 57: Baxter International Inc. – Overview
• 58: Baxter International Inc. – Business segments
• 59: Baxter International Inc. – Key offerings
• 60: Baxter International Inc. – Key customers
• 61: Baxter International Inc. – Segment focus
• 62: Fresenius SE & Co. KGaA – Overview
• 63: Fresenius SE & Co. KGaA – Business segments
• 64: Fresenius SE & Co. KGaA – Key offerings
• 65: Fresenius SE & Co. KGaA – Key customers
• 66: Fresenius SE & Co. KGaA – Segment focus
• 67: GlaxoSmithKline Plc – Overview
• 68: GlaxoSmithKline Plc – Business segments
• 69: GlaxoSmithKline Plc – Key offerings
• 70: GlaxoSmithKline Plc – Key customers
• 71: GlaxoSmithKline Plc – Segment focus
• 72: Lonza Group Ltd. – Overview
• 73: Lonza Group Ltd. – Business segments
• 74: Lonza Group Ltd. – Key offerings
• 75: Lonza Group Ltd. – Key customers
• 76: Lonza Group Ltd. – Segment focus
• 77: Nestle SA – Overview
• 78: Nestle SA – Business segments
• 79: Nestle SA – Key offerings
• 80: Nestle SA – Key customers
• 81: Nestle SA – Segment focus
• 82: Pfizer Inc. – Overview
• 83: Pfizer Inc. – Business segments
• 84: Pfizer Inc. – Key offerings
• 85: Pfizer Inc. – Key customers
• 86: Pfizer Inc. – Segment focus
• 87: Reckitt Benckiser Group Plc – Overview
• 88: Reckitt Benckiser Group Plc – Business segments
• 89: Reckitt Benckiser Group Plc – Key offerings
• 90: Reckitt Benckiser Group Plc – Key customers
• 91: Reckitt Benckiser Group Plc – Segment focus
• 92: Sanofi – Overview
• 93: Sanofi – Business segments
• 94: Sanofi – Key offerings
• 95: Sanofi – Key customers
• 96: Sanofi – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



【掲載企業】

Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Lonza Group Ltd., Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi

★調査レポート[世界の臨床栄養市場2020-2024] (コード:IRTNTR43306)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の臨床栄養市場2020-2024]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆